{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:23:27Z","timestamp":1788261807353,"version":"build-2803163510"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004351","name":"Sultan Qaboos University","doi-asserted-by":"publisher","award":["CR\/SQU-QU\/MED\/21\/01"],"award-info":[{"award-number":["CR\/SQU-QU\/MED\/21\/01"]}],"id":[{"id":"10.13039\/501100004351","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"publisher","award":["IRCC-2021-013"],"award-info":[{"award-number":["IRCC-2021-013"]}],"id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020552","name":"Ministry of Higher Education, Research and Innovation","doi-asserted-by":"publisher","award":["RC\/URG-MED\/BIOC\/22\/01"],"award-info":[{"award-number":["RC\/URG-MED\/BIOC\/22\/01"]}],"id":[{"id":"10.13039\/100020552","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Focal segmental glomerulosclerosis (FSGS) is a serious disease that culminates in kidney failure. Today, FSGS is diagnosed histologically as a progressive scarring of the glomeruli due to gradual loss or damage of the podocyte layer, making it one of the main targets of FSGS therapeutic approaches. However, given that podocytes are terminally differentiated, post mitotic epithelial cells with limited proliferative capacity, they are considered one of the most vulnerable components of the glomeruli.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim and Methods<\/jats:title>\n                    <jats:p>We herein investigated the effect of trehalose, a naturally occurring sugar with low toxicity and high stability, on kidney function using a murine model of adriamycin\u2010induced nephropathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Based on our data, trehalose administration improved proteinuria in mice with FSGS compared to those without FSGS induction (24 h urine protein of 0.30\u00b10.06 versus 0.55\u00b10.08, p-value&amp;lt;0.05, and urine protein to creatinine ratio of 0.78\u00b10.25 versus 1.56\u00b10.17, p-value&amp;lt;0.05, respectively this is accompanied by reduced fibrosis and podocyte damage. Significant reduction in collagen deposition in glomeruli observed in mice treated with trehalose, P-value&amp;lt;0.01 and significant reduction in glomerular basement membrane thickness, P-value&amp;lt;0.001. Moreover, trehalose intake is associated with higher mature podocyte markers at gene and protein expression levels, Nphs1, Nphs2 and Synpo. These favorable effects seem to be mediated mainly via increased WT-1\/EZH2 signaling, which is a key pathway in maintaining normal podocyte function and growth. These effects were also observed in the downstream signaling pathway with lower expression of Mmp-7 and Catenin b1 gene expression (p-value&amp;lt;0.05 and &amp;lt;0.01, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings suggest that trehalose could be a promising therapeutic agent for FSGS, nevertheless, more studies are necessary to confirm our findings and evaluate trehalose efficacy in clinical settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2025.1706617","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T07:07:25Z","timestamp":1762412845000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Trehalose alleviates nephropathy in focal segmental glomerulosclerosis via the upregulation of the WT-1\/EZH2 pathway"],"prefix":"10.3389","volume":"16","author":[{"given":"Maha","family":"Al-Asmakh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa AL","family":"Riyami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miytha","family":"Al Marbuii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadia","family":"Al Sinawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suaad","family":"Al-Badi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal AL","family":"Ismaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"AlKharusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razan","family":"Zadjali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaina","family":"Alharthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Al Mashrafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razan","family":"Al Breiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulaiman","family":"Al-Hashmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Al Lawati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Kassab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Zadjali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41581-020-00339-6","article-title":"Nuclear receptors in podocyte biology and glomerular disease","volume":"17","author":"Agrawal","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1089\/jmf.2021.0007","article-title":"Gum Arabic supplementation suppresses colonic fibrosis after acute colitis by reducing transforming growth factor \u03b21 expression","volume":"24","author":"Al-Araimi","year":"2021","journal-title":"J. Med. Food"},{"key":"B3","doi-asserted-by":"publisher","first-page":"100501","DOI":"10.1016\/j.xkme.2022.100501","article-title":"Efficacy and safety of immunosuppressive therapy in primary focal segmental glomerulosclerosis: a systematic review and meta-analysis","volume":"4","author":"Caster","year":"2022","journal-title":"Kidney Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"29176","DOI":"10.1038\/srep29176","article-title":"The inhibition of EZH2 ameliorates osteoarthritis development through the Wnt\/\u03b2-catenin pathway","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/gcc.20686","article-title":"WNT\/beta-catenin pathway activation in wilms tumors: a unifying mechanism with multiple entries?","volume":"48","author":"Corbin","year":"2009","journal-title":"Genes Chromosom. Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1681\/ASN.2009010019","article-title":"Wnt\/beta-Catenin signaling promotes podocyte dysfunction and albuminuria","volume":"20","author":"Dai","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.22037\/ijpr.2018.2277","article-title":"Trehalose activates autophagy and prevents Hydrogen peroxide-induced apoptosis in the bone marrow stromal cells","volume":"17","author":"Darabi","year":"2018","journal-title":"Iran. J. Pharm. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1172\/JCI72267","article-title":"Cellular and molecular mechanisms in kidney fibrosis","volume":"124","author":"Duffield","year":"2014","journal-title":"J. Clin. Invest"},{"key":"B9","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s13311-023-01343-x","article-title":"Bicalutamide and trehalose ameliorate spinal and bulbar muscular atrophy pathology in mice","volume":"20","author":"Galbiati","year":"2023","journal-title":"Neurotherapeutics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nm.3142","article-title":"Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1","volume":"19","author":"Gebeshuber","year":"2013","journal-title":"Nat. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/hmg\/11.6.651","article-title":"WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis","volume":"11","author":"Guo","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.semnephrol.2013.11.007","article-title":"Autophagy in glomerular health and disease","volume":"34","author":"Hartleben","year":"2014","journal-title":"Semin. Nephrol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/OPTO.S490732","article-title":"Patient experience with ABBV-444, a proof-of-concept Study for a novel artificial tear with trehalose and sodium hyaluronate for dry eye symptoms","volume":"17","author":"Hom","year":"2025","journal-title":"Clin. Optom. (Auckl)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"6524","DOI":"10.1002\/jcp.26583","article-title":"Autophagy induction by trehalose: molecular mechanisms and therapeutic impacts","volume":"233","author":"Hosseinpour-Moghaddam","year":"2018","journal-title":"J. Cell Physiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/ckj\/sfaa110","article-title":"Challenges in primary focal segmental glomerulosclerosis diagnosis: from the diagnostic algorithm to novel biomarkers","volume":"14","author":"Jacobs-Cacha","year":"2021","journal-title":"Clin. Kidney J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1681\/ASN.2007111205","article-title":"Adriamycin alters glomerular endothelium to induce proteinuria","volume":"20","author":"Jeansson","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/j.1523-1755.1998.00825.x","article-title":"Estrogen induces glomerulosclerosis in analbuminemic rats","volume":"53","author":"Joles","year":"1998","journal-title":"Kidney Int."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e113520","DOI":"10.1371\/journal.pone.0113520","article-title":"Trehalose, an mTOR independent autophagy inducer, alleviates human podocyte injury after puromycin aminonucleoside treatment","volume":"9","author":"Kang","year":"2014","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ekir.2021.11.005","article-title":"Urine single-cell RNA sequencing in focal segmental glomerulosclerosis reveals inflammatory signatures","volume":"7","author":"Latt","year":"2022","journal-title":"Kidney Int. Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1440-1797.2010.01383.x","article-title":"Adriamycin nephropathy: a model of focal segmental glomerulosclerosis","volume":"16","author":"Lee","year":"2011","journal-title":"Nephrol. Carlt."},{"key":"B21","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12885-015-1356-0","article-title":"Wilms' tumor gene 1 regulates p63 and promotes cell proliferation in squamous cell carcinoma of the head and neck","volume":"15","author":"Li","year":"2015","journal-title":"BMC Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"640700","DOI":"10.3389\/fphys.2021.640700","article-title":"Histone methyltransferase EZH2: a potential therapeutic target for kidney diseases","volume":"12","author":"Li","year":"2021","journal-title":"Front. Physiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1167\/iovs.61.10.26","article-title":"Trehalose induces autophagy against inflammation by activating TFEB signaling pathway in human corneal epithelial cells exposed to hyperosmotic stress","volume":"61","author":"Liu","year":"2020","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.3390\/jcm11123292","article-title":"Biomarkers in primary focal segmental glomerulosclerosis in optimal diagnostic-therapeutic strategy","volume":"11","author":"Musiala","year":"2022","journal-title":"J. Clin. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"F1376","DOI":"10.1152\/ajprenal.00075.2008","article-title":"Dissociation of NEPH1 from nephrin is involved in development of a rat model of focal segmental glomerulosclerosis","volume":"295","author":"Otaki","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ecoenv.2019.06.007","article-title":"Trehalose suppresses cadmium-activated Nrf2 signaling pathway to protect against spleen injury","volume":"181","author":"Qu","year":"2019","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"B27","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3390\/cells12030412","article-title":"Autophagy as a therapeutic target for chronic kidney disease and the roles of TGF-\u03b21 in autophagy and kidney fibrosis","volume":"12","author":"Ruby","year":"2023","journal-title":"Cells"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.steroids.2010.06.016","article-title":"Impact of the estrus cycle and reduction in estrogen levels with aromatase inhibition, on renal function and nitric oxide activity in female rats","volume":"75","author":"Santmyire","year":"2010","journal-title":"Steroids"},{"key":"B29","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1056\/NEJM199604043341402","article-title":"Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis","volume":"334","author":"Savin","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"B31","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1159\/000508099","article-title":"Focal segmental glomerulosclerosis: State-of-the-Art and clinical perspective","volume":"144","author":"Shabaka","year":"2020","journal-title":"Nephron"},{"key":"B32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.diabres.2009.10.022","article-title":"Evaluation of podocyte lesion in patients with diabetic nephropathy: wilms' tumor-1 protein used as a podocyte marker","volume":"87","author":"Su","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1039\/c9mt00227h","article-title":"Trehalose alleviates cadmium-induced brain damage by ameliorating oxidative stress, autophagy inhibition, and apoptosis","volume":"11","author":"Tang","year":"2019","journal-title":"Metallomics"},{"key":"B34","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/14728214.2020.1803276","article-title":"Emerging drugs for treatment of focal segmental glomerulosclerosis","volume":"25","author":"Trachtman","year":"2020","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"B35","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1474-4422(25)00173-5","article-title":"Safety and efficacy of trehalose in amyotrophic lateral sclerosis (HEALEY ALS Platform Trial): an adaptive, phase 2\/3, double-blind, randomised, placebo-controlled trial","volume":"24","author":"Trial","year":"2025","journal-title":"Lancet Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1017\/S0007114511006714","article-title":"Reduced glycaemic and insulinaemic responses following trehalose and isomaltulose ingestion: implications for postprandial substrate use in impaired glucose-tolerant subjects","volume":"108","author":"van Can","year":"2012","journal-title":"Br. J. Nutr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1111\/j.1523-1755.2004.00964.x","article-title":"Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies","volume":"66","author":"van den Berg","year":"2004","journal-title":"Kidney Int."},{"key":"B38","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3324\/haematol.2021.280294","article-title":"Crosstalk between beta-catenin and WT1 signaling activity in acute myeloid leukemia","volume":"108","author":"Wagstaff","year":"2023","journal-title":"Haematologica"},{"key":"B39","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.freeradbiomed.2017.03.012","article-title":"WT1 ameliorates podocyte injury via repression of EZH2\/\u03b2-catenin pathway in diabetic nephropathy","volume":"108","author":"Wan","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fmed.2018.00098","article-title":"Molecular mechanisms of proteinuria in focal segmental glomerulosclerosis","volume":"5","author":"Wen","year":"2018","journal-title":"Front. Med. (Lausanne)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"F68","DOI":"10.1152\/ajprenal.00669.2011","article-title":"Interleukin-18 binding protein therapy is protective in adriamycin nephropathy","volume":"304","author":"Wyburn","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"115617","DOI":"10.1016\/j.biopha.2023.115617","article-title":"CDDO-Me ameliorates podocyte injury through anti-oxidative stress and regulation of actin cytoskeleton in adriamycin nephropathy","volume":"167","author":"Xu","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B43","doi-asserted-by":"publisher","first-page":"F74","DOI":"10.1152\/ajprenal.00114.2017","article-title":"Autophagy is activated to protect against podocyte injury in adriamycin-induced nephropathy","volume":"313","author":"Yi","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","article-title":"Signaling pathways of chronic kidney diseases, implications for therapeutics","volume":"7","author":"Yuan","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1096\/fj.12-205583","article-title":"SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high-fat-diet-fed mice","volume":"26","author":"Zadjali","year":"2012","journal-title":"FASEB J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.kint.2018.10.032","article-title":"Wnt\/\u03b2-catenin links oxidative stress to podocyte injury and proteinuria","volume":"95","author":"Zhou","year":"2019","journal-title":"Kidney Int."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1941038","DOI":"10.1155\/2022\/1941038","article-title":"Decoding the mechanism behind the pathogenesis of the focal segmental glomerulosclerosis","volume":"2022","author":"Zhu","year":"2022","journal-title":"Comput. Math. Methods Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1681\/ASN.2016050519","article-title":"Targeting mTOR signaling can prevent the progression of FSGS","volume":"28","author":"Zschiedrich","year":"2017","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1706617\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T07:07:26Z","timestamp":1762412846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1706617\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":48,"alternative-id":["10.3389\/fphar.2025.1706617"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1706617","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"article-number":"1706617"}}